8-K ·Filed Mar 12, 2026
8-K Item 2.02: Earnings release
Actionable Insight • Neutral
Await public release or SEC document update for actual financial results or disclosures. Monitor company press releases or investor relations for corroboration.
Final — all horizons settled through T+60d ⚠ clustered
MCRB ▼ -26.74% at T+60d
NEUTRAL call -26.74% · α vs SPY -37.44% · entry $9.05 → $6.63
T+1d
-4.64%
call -4.64% · α -4.04%
$8.63
settled 8mo ago
T+5d
+0.33%
call +0.33% · α +1.31%
$9.08
settled 7mo ago
T+20d
-8.07%
call -8.07% · α -10.04%
$8.32
settled 7mo ago
T+60d
-26.74%
call -26.74% · α -37.44%
$6.63
settled 5mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The 8-K reports Items 2.02 (Results of Operations) and 7.01 (Regulation FD Disclosure), suggesting Seres Therapeutics may have released earnings or forward-looking information, but no financial details or commentary can be confirmed without the actual filing.
Key Facts
- Filing is an 8-K with Items 2.02 and 7.01 disclosed, indicating potential release of earnings or public business updates.
- Item 9.01 indicates inclusion of financial statements and exhibits, but content is inaccessible.
- No document text available to confirm financial results, guidance, or strategic disclosures.
Financial Impact
Not specified
Risk Factors
- Inability to assess actual financial performance or forward guidance.
- Potential for material information to be misinterpreted due to lack of source document.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Documents Analyzed
Report based on filing metadata.
12 reports for MCRB
80% Hit rate @ T+20 Went positive at some point 4 of 5 best @ T+60▲ +36.27%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $1.98 | awaiting T+20 | — | $1.82 (+8.08%) |
Aug 24, 2026 9w ago | EFFECT | $4.66 $4.02 | ▲ +13.73% | ▲ +15.05% | $1.82 (+60.94%) |
Aug 5, 2026 11w ago | 8-K | $5.01 $5.54 | ▲ +10.69% | ▲ +11.29% | $1.82 (−63.64%) |
Jul 8, 2026 15w ago | 8-K | $7.14 $5.01 | ▼ −29.90% | ▼ −33.17% | $1.82 (−74.51%) |
Jun 5, 2026 20w ago | 8-K | $6.63 $7.71 | ▲ +16.29% | ▲ +14.43% | $1.82 (−72.55%) |
Jun 5, 2026 20w ago | Press Release | $6.63 $7.71 | ▲ +16.29% | ▲ +14.43% | $1.82 (−72.55%) |
May 19, 2026 22w ago | Insider Cluster | $7.66 $6.61 | ▼ −13.71% | ▼ −14.45% | $1.82 (−76.24%) |
May 5, 2026 25w ago | 8-K | $7.50 $7.33 | ▲ +2.27% | ▲ +7.22% | $1.82 (+75.73%) |
May 5, 2026 25w ago | Press Release | $7.50 $7.33 | ▲ +2.27% | ▲ +7.22% | $1.82 (+75.73%) |
May 4, 2026 25w ago | Press Release | $7.69 $7.64 | ▼ −0.65% | ▼ −6.30% | $1.82 (−76.33%) |
Showing 10 of 12
US Market Status
Market Open — Closes in 3h 12m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers